Bristol-myers Squibb Company
- global biopharmaceutical
- medicines
- clinical trials
- product development
- therapeutic area
- middle-income countries
Open positions
Openings read from Bristol-myers Squibb Company’s own job board on Workday, last checked NOV 15, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Regional Business Director (RBD), RayzeBio- West RegionField - United States - US · posted NOV 14, 2026
- Senior Therapeutic Area Specialist, Cardiovascular Community - Gainesville, FLGainesville - FL - US · posted NOV 14, 2026
- Senior Therapeutic Area Specialist, Cardiovascular Community – Lancaster, PALancaster - PA - US; Williamsport - PA - US · posted NOV 14, 2026
- Senior Therapeutic Area Specialist, Cardiovascular Community - Dallas S, TXDallas - TX; Irving - TX · posted NOV 14, 2026
- Associate Director, Commercialization BI&T Product Manager Patient Support PlatformsPrinceton - NJ - US · posted NOV 14, 2026
- Data & Quantitative Sciences Statistical Programming Intern - Summer 2027Princeton - NJ - US; Madison - Giralda - NJ - US; Brisbane - CA - US; Cambridge Crossing - MA - US; Remote - United States - US; San Diego - CA - US; Seattle 1616 Eastlake - WA - US · posted NOV 14, 2026
- Senior Associate Scientist, Routine AssaysCambridge - MA - US · posted NOV 14, 2026
- Associate Director, US Incentive CompensationPrinceton - NJ - US · posted NOV 14, 2026
- Director, Advertising and Promotion Regulatory AffairsRemote - United States - US · posted NOV 14, 2026
- Manager, ManufacturingBothell - WA - US · posted NOV 14, 2026
1,270 more on the company’s board
Supplier designations
Self-certified by the company in its SAM.gov registration
Terms of sale
PricingUnless otherwise agreed in writing, the Price: (a) is fixed in CZK and is not subject to any incremental cost as a result of currency fluctuations;
Unless otherwise agreed in writing, the Price: (a) is fixed in CZK and is not subject to any incremental cost as a result of currency fluctuations; (b) is inclusive of all requirements resulting from set up "terms of sale" (c) is exclusive of VAT at the rate established by the Czech Republic law, which is stated on the invoice; (d) Any change in the set Price will be notified in writing to the Purchaser 14 days prior to effective date of such a change. 4.2. The Purchaser shall pay all undisputed amounts within the due date as set out on the respective invoice. If the payment due date falls on a day which is not a business day, then the payment due date 4.3. If the Purchaser fails to pay an undisputed invoice by the due date for payment, described in clause 4.1 above, the Seller may charge default interest on the unpaid amount at the rate and in the manner prescribed by Czech law from the due date until the date of actual payment. 4.4. Notwithstanding the above, other terms of payment may be set up by the Seller and communicated to the Purchaser in a written form. 5. TITLE OF PRODUCTS OWNERSHIP 5.1. Place and time of the transfer of the Products ownership are determined by "Terms of sale". The ownership to the Products, free of prior rights or interests of the Seller, passes to the Purchaser upon the delivery of the
“Unless otherwise agreed in writing, the Price” · Standardni obchodni podminky BMS Ceska republika 10.2024 · open the document (PDF)
Cancellation and returnsPurchaser in conformance with the Purchase Order. 3.2. The Seller shall inform the Purchaser on the unavailability of the ordered Products and anticipated deadline for providing…
Purchaser in conformance with the Purchase Order. 3.2. The Seller shall inform the Purchaser on the unavailability of the ordered Products and anticipated deadline for providing to the Purchaser the remaining part of the Purchase Order. 3.3. Upon arrival of the Products at the Purchaser's pharmaceutical warehouse, the Purchaser shall check the delivery for possible quantitative shortcomings and damage. Should the Products be in recognizably defective state or should quantitative shortcomings be detected, the Purchaser shall immediately inform the Seller and cooperate with the Seller in solving the issues caused by the defects. The above obligation shall not apply to the Products with hidden defects, however the Purchaser shall notify such hidden defects to the Seller in the form of a complaint protocol, providing detailed information pertaining to the Product, delivery and defects found, immediately after discovery of the defect and shall provide all necessary assistance that may be reasonably requested by the Seller in this regard. 3.4. In the event that upon the arrival of the Products at the Purchaser’s warehouse it is determined that the Products are in recognizably defective state, the
“Purchaser in conformance with the Purchase Order” · Standardni obchodni podminky BMS Ceska republika 10.2024 · open the document (PDF)
From Bristol-myers Squibb Company’s own terms and conditions of sale · read October 18, 2026 · not verified by FactoryRegistry
Patents
3,751 US patents granted 1990–2025, 429 of them in the five years to SEP 2025, including 56 design patents.
- Oxabicyclo acids as LPA antagonistsUS 12,428,430 · granted SEP 30, 2025
- Pyrimidinones as factor XIA inhibitorsUS 12,428,421 · granted SEP 30, 2025
- ImmunomodulatorsUS 12,421,278 · granted SEP 23, 2025
- Tricyclic heteroaryl compounds useful as IRAK4 inhibitorsUS 12,421,230 · granted SEP 23, 2025
- Amorphous and crystalline forms of IDO inhibitorsUS 12,421,195 · granted SEP 23, 2025
Newest 5 shown · Granted to Bristol-Myers Squibb Company · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
20 FACILITIESWARN Act notices
- WARN notice effective DEC 17, 2026 · 265 employees · Princeton, NJ
- WARN notice effective JUL 16, 2026 · 206 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective MAY 21, 2026 · 247 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective FEB 12, 2026 · 110 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective DEC 11, 2025 · 282 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective SEP 25, 2025 · 68 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective MAY 22, 2025 · 223 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective MAY 9, 2025 · 516 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective APR 24, 2025 · 67 employees · Bristol-myers Squibb CO - Princeton Pike Site
- WARN notice effective MAY 31, 2023 · 48 employees · Princeton, NJ
- Plant closing notice effective NOV 13, 2018 · 86 employees · Bristol-myers Squibb Research & Development — this notice sets that plant’s status
- Plant closing notice effective APR 3, 2018 · 149 employees · Bristol-myers Squibb Research & Development — this notice sets that plant’s status
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


